TLR7/8-

Xu-Guang Yin1, Guo-Zuo Tong1, Si-Qi Huang1

  • 1Center for Drug Delivery System Research, School of Medicine, Shaoxing University, 900 Chengnan Avenue, Shaoxing, Zhejiang 312000, China. kewuzhu@usx.edu.cn.

Chemical communications (Cambridge, England)
|August 29, 2025
PubMed
概括

与素结合的新型托尔类受体7/8激活剂 (imidazoquinoline) 显示出与盐相比,它是癌症疫苗的优质辅助剂.